Every material Form 8-K Microchip Technology filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Microchip reported second-quarter fiscal 2026 net sales of $1.140 billion, up 6% from the prior quarter and above the $1.130 billion guidance midpoint, but down 2% from a year earlier. GAAP net income attributable to common stockholders fell to $13.9 million from $78.4 million, and the company guided third-quarter net sales to a midpoint of $1.129 billion, slightly below the second quarter.
Net sales of $1.140 billion, versus $1.164 billion in the year-ago quarter and a guidance midpoint of $1.130 billion.
GAAP diluted EPS of $0.03 versus $0.14 a year earlier; non-GAAP diluted EPS of $0.35 versus $0.46.
Third-quarter fiscal 2026 net sales guidance of $1.109 billion to $1.149 billion; GAAP diluted EPS guidance of $(0.02) to $0.02.
Quarterly dividend of 45.5 cents per share declared, payable December 9, 2025 to holders of record on November 24, 2025.
For the quarter ended June 30, 2025, Microchip reported net sales of $1.0755 billion, up 10.8% sequentially, down 13.4% from a year earlier, and above the $1.0575 billion midpoint of its May 29, 2025 guidance. The company posted a GAAP net loss attributable to common stockholders of $46.4 million, or $0.09 per diluted share, compared with GAAP net income of $129.3 million a year earlier, and guided September quarter net sales to $1.130 billion plus or minus $20.0 million.
Net sales were $1.0755 billion, up 10.8% sequentially and down 13.4% from $1.241 billion in the year-earlier quarter.
GAAP net loss attributable to common stockholders was $46.4 million, or $0.09 per diluted share; non-GAAP net income was $154.7 million, or $0.27 per diluted share.
Inventory dollars fell $124.4 million during the quarter.
Board declared a quarterly common dividend of 45.5 cents per share, payable September 5, 2025 to holders of record on August 22, 2025.
Microchip Technology reported fourth-quarter fiscal 2025 results for the quarter ended March 31, 2025. Net sales were $970.5 million, down 26.8% from a year earlier but above the midpoint of the company's $960.0 million guidance, and the company guided first-quarter fiscal 2026 net sales to $1.020 billion to $1.070 billion. GAAP results were a net loss attributable to common stockholders of $156.8 million, or $0.29 per diluted share, compared with a profit a year earlier, and included restructuring charges.
Q4 net sales of $970.5 million, down 26.8% from $1.326 billion a year earlier and above the $960.0 million guidance midpoint.
GAAP net loss attributable to common stockholders of $156.8 million, or $0.29 per diluted share, versus net income of $154.7 million a year earlier.
Non-GAAP EPS of $0.11 per diluted share, within the $0.05 to $0.15 guidance range given February 6, 2025.
Q1 fiscal 2026 net sales guidance of $1.020 billion to $1.070 billion; quarterly dividend of 45.5 cents per share payable June 5, 2025.
Microchip Technology's board appointed Rick Cassidy, a senior vice president at Taiwan Semiconductor Manufacturing Co. (TSMC) and chairman of TSMC Arizona, as a director effective May 2, 2025, and increased the board size from 6 to 7. The filing says Cassidy has not yet been named to any board committee and will receive the standard non-employee director compensation.
Rick Cassidy appointed to the board effective May 2, 2025; board appointment approved May 1, 2025
Board size increased from 6 to 7 directors
Cassidy is senior vice president of corporate strategy development at TSMC and chairman of TSMC Arizona
No committee assignment yet; he will join the standard non-employee director compensation plan
On March 25, 2025, Microchip Technology entered a Second Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent, replacing its existing credit agreement dated December 16, 2021. The unsecured revolving facility allows borrowings of up to $2.25 billion, and no loans or letters of credit were outstanding at signing. The agreement runs until March 25, 2030, and includes covenants that restrict dividends, stock repurchases and acquisitions, as well as a change of control default.
Unsecured revolving facility of up to $2.25 billion, with a $250 million foreign currency sublimit, a $25 million letter of credit sublimit and a $20 million swingline sublimit
No revolving loans or letters of credit were outstanding as of March 25, 2025
Commitments terminate March 25, 2030; the company may add up to $1.0 billion in incremental term loans or commitment increases
Financial maintenance covenants require compliance with a maximum total leverage ratio and a minimum interest coverage ratio
Microchip Technology agreed on March 20, 2025 to sell 27,000,000 depositary shares of its 7.50% Series A Mandatory Convertible Preferred Stock, and underwriters exercised their option for 2,700,000 more on March 21. The offering closed March 25, 2025, and the preferred stock will convert into common shares around March 15, 2028, which could dilute common shareholders, while preferred holders receive dividends and liquidation priority ahead of common stock.
27,000,000 depositary shares were sold, plus 2,700,000 over-allotment shares exercised in full on March 21, 2025; the offering closed March 25, 2025.
Each depositary share is a 1/20th interest in a preferred share with a $1,000 liquidation preference and a 7.50% annual dividend, payable quarterly at the board's discretion.
Each preferred share converts around March 15, 2028 into between 16.0060 and 19.6080 common shares, based on the average stock price over a 20-trading-day period.
Capped call transactions with several banks have an initial cap price of $71.40 per share and are generally expected to reduce potential dilution; common dividends and repurchases are restricted while preferred dividends are unpaid.
Microchip Technology announced additional restructuring, including about 2,000 headcount reductions across its fabs, Philippines backend facility and business units, and a closure of its Tempe, Arizona Fab 2 that is now expected to finish in May 2025, several months earlier than planned. The company estimates $30 million to $40 million in related costs and about $45 million in charges tied to canceling or modifying long-term wafer supply agreements, against expected annualized operating expense savings of $90 million to $100 million.
About 2,000 headcount reductions, starting March 3, 2025, with full implementation expected by the end of the June 2025 quarter
Estimated restructuring costs of $30 million to $40 million, including cash severance and other related charges
Expected charges of about $45 million tied to canceling or modifying long-term wafer foundry supply agreements
Expected annualized operating expense reductions of $90 million to $100 million, plus about $25 million in additional factory employment cost savings
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Microchip Technology filing is on SEC EDGAR ↗. 8-K briefs of other companies →